Market update
The Company is pleased to announce that it has today separately released the top-line interim 1-year
PROTECT Clinical Trial results. PROTECT is a multi-center, randomised, double-masked clinical trial being
conducted in eight sites in four countries. For further details, please refer to the announcement entitled:
“Visioneering Announces Positive Top-Line Interim 1-Year Data for their NaturalVue® Multifocal 1 Day Contact
Lens from the PROTECT Multi-center, Randomized, Double-Masked Clinical Trial for Myopia Progression
Control”.
Love to. Where is it?
Ann: VTI Announces Capital Raising to Fund Growth, page-2
Add VTI (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
17.0¢ |
Change
-0.005(2.86%) |
Mkt cap ! $9.356M | |||
| Open | High | Low | Value | Volume |
| 17.5¢ | 17.5¢ | 17.0¢ | $285 | 1.629K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 50000 | 15.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 17.0¢ | 12513 | 1 |
View Market Depth
| Last trade - 11.55am 10/06/2024 (20 minute delay) ? |
| VTI (ASX) Chart |